Susan Berson and Brent Henry Recognized as Health Care Trailblazers by the National Law Journal

Mintz advised Aspen Aerogels, Inc. (NYSE: ASPN), a technology leader in sustainability and electrification solutions, on a registered follow-on offering of 4,887,500 shares of its common stock, which included 637,500 shares pursuant to the underwriters’ option to purchase additional shares of its common stock. The price to the public in the offering was $20.00 per share and the gross proceeds to Aspen from the offering were approximately $98 million, before deducting underwriting discounts and commissions and estimated offering expenses.

Of Counsel Michelle Capezza’s insights were included in a Fiduciary News article about the SECURE Act 2.0’s auto-enrollment requirement. 

Mintz advised Charlesbank Capital Partners (“Charlesbank”), a middle-market private equity firm with more than $22 billion in total assets, on a strategic investment with IMPLAN Group LLC (“IMPLAN”), a leading provider of economic impact data and analytical software. 

Insights from Member Eoin Beirne were featured in a recent Law360 article about what the incoming Trump administration’s pick for Massachusetts US attorney could mean for judicial activity from the office and the uncertainties that remain.

Member Theresa Carnegie was quoted by Law360 in an article about the unknowns of Robert F. Kennedy Jr.’s health policies following his nomination by President-elect Trump to head the Department of Health and Human Services. 

An article written by International Life Sciences Chair Cheryl Reicin and Associate Luke Jeagal was published in BIOTECanada's Insights Magazine focusing on how life sciences companies should structure themselves so that they have cross-border opportunities.